Merck Narrows Sales Outlook With Gardasil Lagging in China

Merck Narrows Sales Outlook With Gardasil Lagging in China

Merck & Co. lowered the top end of its full-year sales forecast after demand for its HPV vaccine fell for a second straight quarter in China.

Merck narrows sales outlook with Gardasil lagging in China

MERCK lowered the top end of its full-year sales guidance after demand for its HPV vaccine fell for a second straight quarter in China.

Merck Stock Dives As Guidance Cut Proves Gruesome

Merck spooked investors on Thursday with a guidance cut after sales of its diabetes drugs and HPV vaccine lagged third-quarter forecasts. The post Merck Spooks Investors With A Guidance Cut In The Wake Of Light Diabetes, HPV Shot Sales appeared first on Investor's Business Daily.

Gardasil demand in China sinks, and Merck expects the same next quarter

Merck said sales of its HPV vaccine Gardasil — its second-largest product — dipped again in the third quarter, citing reduced demand in China, where the shot is only approved for females. Gardasil’s sales were down 11 ...